Change - Announcement of Cessation::Resignation of Executive Director - Dr Danny Oh Beng Teck

Issuer & Securities

Issuer/ Manager
MATEX INTERNATIONAL LIMITED
Securities
MATEX INTERNATIONAL LIMITED - SG1P13916389 - M15
Stapled Security
No

Announcement Details

Announcement Title
Change - Announcement of Cessation
Date &Time of Broadcast
06-Nov-2025 00:11:07
Status
New
Announcement Sub Title
Resignation of Executive Director - Dr Danny Oh Beng Teck
Announcement Reference
SG251106OTHRKAAU
Submitted By (Co./ Ind. Name)
Liu Shen
Designation
Executive Director
Description (Please provide a detailed description of the event in the box below)
Resignation of Dr. Danny Oh Beng Teck as an Executive Director of the Company with effect from 5 November 2025.

This announcement has been reviewed by the Company's sponsor, ZICO Capital Pte. Ltd. (the "Sponsor").

This announcement has not been examined or approved by the Singapore Exchange Securities Trading Limited (the "SGX-ST") and the SGX-ST assumes no responsibility for the contents of this announcement, including the correctness of any of the statements or opinions made or reports contained in this announcement.

The contact person for the Sponsor is Ms. Goh Mei Xian, ZICO Capital Pte. Ltd. at 77 Robinson Road, #06-03 Robinson 77, Singapore 068896, telephone (65) 6636 4201.

Additional Details

Name of person
Danny Oh Beng Teck
Age
63
Is effective date of cessation known?
Yes
If yes, please provide the date.
05/11/2025
Detailed reason(s) for cessation
Dr. Danny Oh Beng Teck ("Dr. Oh") has tendered his resignation as an Executive Director of the Company on 5 November 2025. Dr. Oh informed the board of directors of the Company that the Company's operations are currently stabilizing, and the transition team can now proceed with a more strategic direction and guidance under the leadership of the new Executive Director of the Company, Dr. Liu Shen, and the appointment of a new Chief Executive Officer of the Company, Mr. Chen Hongbo.

Following his resignation, Dr. Oh has also relinquished his position as a member of the Nominating Committee.

The Company and Dr. Oh have mutually agreed for Dr. Oh to cease to be an Executive Director of the Company with effect from 5 November 2025. However, Dr. Oh will continue to stay with the Company until 5 December 2025 to facilitate the handover and ensure a smooth transition.

After having interviewed Dr. Oh, and to the best of its knowledge, the Company's Sponsor is satisfied that, save as disclosed in this announcement, there are no other material reasons for the resignation of Dr. Oh as an Executive Director of the Company.
Are there any unresolved differences in opinion on material matters between the person and the board of directors, including matters which would have a material impact on the group or its financial reporting?
No
Is there any matter in relation to the cessation that needs to be brought to the attention of the shareholders of the listed issuer?
No
Any other relevant information to be provided to shareholders of the listed issuer?
No
Date of appointment to current position
16/09/2025
Job title (e.g. Lead ID, AC Chairman, AC Member etc.)
Executive Director and a member of the Nominating Committee
Role and responsibilities
As an Executive Director of the Company, Dr. Oh was in charge of transition and strategic directions of the Company. Dr. Oh also assumed the role and responsibilities as a member of the Nominating Committee.
Does the AC have a minimum of 3 members (taking into account this cessation)?
Yes
Number of independent directors currently resident in Singapore (taking into account this cessation)
3
Do independent directors make up at least one-third of the board (taking into account this cessation)?
Yes
Number of cessations of appointments specified in Mainboard Rule 704(7) or Catalist Rule 704(6) over the past 12 months
6
Shareholding interest in the listed issuer and its subsidiaries?
No
Familial relationship with any director and/or substantial shareholder of the listed issuer or of any of its principal subsidiaries
Dr. Oh is a cousin of Mr Yeo Hock Huat, a substantial shareholder of the Company.
Other Directorships
Past (for the last 5 years)
Imperium Crown Limited
China Powerplus Limited
NM Backer Corporation Pte Ltd
D.O Recruitment Agency Pte Ltd
Mclean Technologies Berhad
Present
ecoWise Holdings Limited
Cambrian Engineering Corporation Pte Ltd
Cambrian Academy Pte Ltd
Cables & Utilities Detection Services Pte Ltd
Cambrian Lab Pte Ltd
Matex Holdings Pte. Ltd.
MatexMega Pte. Ltd.
Unimatex Sdn. Bhd.